The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Renz Justin A since 2015.
This trader's CIK number is 1466562.
At the time of last reporting, Renz Justin A was the Chief Financial Officer of Ardelyx, Inc.. (stock ticker symbol ARDX).
Also see all insider trading activities at Ardelyx, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | KPTI | 0 | $0 | 4,342 | $35,543 | 15,000 | $0 |
| 2015 | KPTI | 5,000 | $148,555 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ARDX | 0 | $0 | 19,426 | $100,275 | 0 | $0 |
| 2024 | ARDX | 0 | $0 | 15,890 | $102,926 | 0 | $0 |
| 2023 | ARDX | 0 | $0 | 233,630 | $1,463,370 | 75,000 | $74,250 |
| 2022 | ARDX | 6,000 | $3,714 | 79,346 | $55,483 | 0 | $0 |
| 2021 | ARDX | 0 | $0 | 2,494 | $9,990 | 0 | $0 |
| 2020 | ARDX | 0 | $0 | 3,714 | $20,371 | 0 | $0 |
1. Karyopharm Therapeutics Inc. (KPTI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-11-09 | KPTI | Sale | 4,342 | 8.19 | 35,543 |
| 2016-11-05 | KPTI | Option Ex | 15,000 | .00 | 0 |
| 2015-04-02 | KPTI | Buy | 5,000 | 29.71 | 148,555 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-21 | ARDX | Sale | 7,037 | 5.93 | 41,743 |
| 2025-05-20 | ARDX | Sale | 7,218 | 4.08 | 29,456 |
| 2025-02-20 | ARDX | Sale | 5,171 | 5.62 | 29,076 |
| 2024-11-20 | ARDX | Sale | 5,260 | 4.79 | 25,221 |
| 2024-08-20 | ARDX | Sale | 5,289 | 5.86 | 30,993 |
| 2024-02-20 | ARDX | Sale | 5,341 | 8.75 | 46,712 |
| 2023-12-26 | ARDX | Option Ex | 75,000 | .99 | 74,250 |
| 2023-12-26 | ARDX | Sale | 225,000 | 6.36 | 1,430,100 |
| 2023-11-20 | ARDX | Sale | 2,873 | 4.36 | 12,532 |
| 2023-08-21 | ARDX | Sale | 2,884 | 3.55 | 10,243 |
| 2023-05-23 | ARDX | Sale | 2,873 | 3.65 | 10,495 |
| 2022-11-22 | ARDX | Sale | 1,504 | 1.95 | 2,925 |
| 2022-11-22 | ARDX | Sale | 1,504 | 1.95 | 2,925 |
| 2022-08-31 | ARDX | Buy | 3,000 | .62 | 1,857 |
| 2022-08-31 | ARDX | Buy | 3,000 | .62 | 1,857 |
| 2022-08-22 | ARDX | Sale | 1,498 | .98 | 1,469 |
| 2022-06-06 | ARDX | Sale | 73,312 | .64 | 47,139 |
| 2022-05-20 | ARDX | Sale | 1,528 | .67 | 1,025 |
| 2021-11-22 | ARDX | Sale | 643 | .99 | 637 |
| 2021-08-20 | ARDX | Sale | 631 | 1.32 | 832 |
| 2021-05-20 | ARDX | Sale | 612 | 7.09 | 4,337 |
| 2021-02-22 | ARDX | Sale | 608 | 6.88 | 4,184 |
| 2020-09-15 | ARDX | Sale | 3,714 | 5.49 | 20,371 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Renz Justin A (Chief Financial Officer of Ardelyx, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.